Video

Patient Subgroups and Educational Opportunities in Rare Dermatological Disorders

Author(s):

Raj Chovatiya, MD, PhD,Boni Elewski, MD

Dermatological experts discuss challenges that are associated with the use of standard and emerging treatments in special patient population.

Related Videos
AI in Dermatology: Emerging Insights and Diverging Perspectives
Skin of Color Savvy: News Update—Addressing Disparities, Black History Month, & Mentorship Opportunities
Medical Sisterhood: James Del Rosso, DO
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Importance of Birch Triterpene Findings for Epidermolysis Bullosa, with Anna Bruckner, MD
Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD
Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Crisis Point: Benzene Concerns in Acne Care
Related Content
Patch Test Highlights Allergens Impacting Alopecia Areata, Other Hair Conditions
February 21st 2025

Patch Test Highlights Allergens Impacting Alopecia Areata, Other Hair Conditions

Tim Smith
Skin of Color Savvy: Pigmentary Disorders in Skin of Color, with Nada Elbuluk, MD, and Michelle Rodrigues, MBBS
February 3rd 2025

Skin of Color Savvy: Pigmentary Disorders in Skin of Color, with Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS

Valerie Jaroenpuntaruk, MD I Credit: the Mayo Clinic
February 21st 2025

Omalizumab Linked to Greatest Rate of Hypersensitivity Reactions in Atopic Diseases

Chelsie Derman
Default thumbnail for The Medical Sisterhood podcast
January 16th 2025

The Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

Mona Shahriari, MD, FAAD Shadi Kourosh, MD, MPH
Pediatric Atopic Dermatitis Most Effectively Treated with Upadacitinib, Study Finds
February 20th 2025

Pediatric Atopic Dermatitis Most Effectively Treated with Upadacitinib, Study Finds

Tim Smith
Martin Metz, MD, Deputy Director, Head of Translational Research and Clinical Studies, Institute of Allergology, Charite-Universitatsmedizin Berlin, Germany
February 20th 2025

Add-on Remibrutinib Quickly Improves Urticaria Control in CSU

Victoria Johnson
© 2025 MJH Life Sciences

All rights reserved.